1-5 of 5
Jantien Wanders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors

Maja J.A. de Jonge, Ate van der Gaast, André S.T. Planting, Leny van Doorn, Aletta Lems, Inge Boot, Jantien Wanders, Masahiko Satomi, Jaap Verweij
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3806–3813.
https://doi.org/10.1158/1078-0432.CCR-04-1937
Published: 16 May 2005
View article titled, Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors
Open the PDF for Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors in another window
Journal Articles

Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors

Otto Soepenberg, Maja J. A. de Jonge, Alex Sparreboom, Peter de Bruin, Ferry A. L. M. Eskens, Gerda de Heus, Jantien Wanders, Peter Cheverton, Murray P. Ducharme, Jaap Verweij
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (2): 703–711.
https://doi.org/10.1158/1078-0432.703.11.2
Published: 08 February 2005
View article titled, Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors
Open the PDF for Phase I and Pharmacokinetic Study of DE-310 in Patients with Advanced Solid Tumors in another window
Journal Articles

Phase I and Pharmacokinetic Study of E7070, a Chloroindolyl-Sulfonamide Anticancer Agent, Administered on a Weekly Schedule to Patients with Solid Tumors

Christian Dittrich, Herlinde Dumez, Hilary Calvert, Axel Hanauske, Marije Faber, Jantien Wanders, Murray Yule, Miroslav Ravic, Pierre Fumoleau
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (14): 5195–5204.
Published: 12 November 2003
View article titled, Phase I and Pharmacokinetic Study of E7070, a Chloroindolyl-Sulfonamide Anticancer Agent, Administered on a Weekly Schedule to Patients with Solid Tumors
Open the PDF for Phase I and Pharmacokinetic Study of E7070, a Chloroindolyl-Sulfonamide Anticancer Agent, Administered on a Weekly Schedule to Patients with Solid Tumors in another window
Journal Articles

Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 E6 and E7 Genes, in Women with Progressive Cervical Cancer

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin, Harald Sommer, Volkmar Nuessler, Achim Schneider, Malcom Adams, Toli S. Onon, Thomas Bauknecht, Uwe Wagner, Karlijn Kroon, Julian Hickling, Christopher M. Boswell, Simon N. Stacey, Henry C. Kitchener, Jennifer Gillard, Jantien Wanders, John St. C. Roberts, Heinz Zwierzina
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3676–3685.
Published: 01 December 2002
View article titled, Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 <em>E6</em> and <em>E7</em> Genes, in Women with Progressive Cervical Cancer
Open the PDF for Safety and Immunogenicity of TA-HPV, a Recombinant Vaccinia Virus Expressing Modified Human Papillomavirus (HPV)-16 and HPV-18 <em>E6</em> and <em>E7</em> Genes, in Women with Progressive Cervical Cancer in another window
Journal Articles

Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors

Ferry A. L. M. Eskens, Gudrun A. Greim, Cornelia van Zuylen, I. Wolff, Louis J. Denis, André S. Th. Planting, Frits A. Muskiet, Jantien Wanders, Nicolas C. Barbet, Les Choi, Renaud Capdeville, Jaap Verweij, A-R. Hanauske, Uta Bruntsch, for the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (5): 1736–1743.
Published: 01 May 2000
View article titled, Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors
Open the PDF for Phase I and Pharmacological Study of Weekly Administration of the Polyamine Synthesis Inhibitor SAM 486A (CGP 48 664) in Patients with Solid Tumors in another window